Stratec SE (0RAR.L)
EUR 23.06
(3.85%)
EUR 23.06
(3.85%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 64.84 Million EUR | -18.42% |
| 2022 | 79.49 Million EUR | -9.37% |
| 2021 | 87.71 Million EUR | 27.14% |
| 2020 | 68.98 Million EUR | 32.41% |
| 2019 | 52.1 Million EUR | -2.57% |
| 2018 | 53.48 Million EUR | -20.77% |
| 2017 | 67.49 Million EUR | 9.51% |
| 2016 | 61.63 Million EUR | 12.0% |
| 2015 | 55.03 Million EUR | 22.47% |
| 2014 | 44.93 Million EUR | 7.6% |
| 2013 | 41.76 Million EUR | 5.54% |
| 2012 | 39.57 Million EUR | -37.13% |
| 2011 | 62.94 Million EUR | 17.33% |
| 2010 | 53.64 Million EUR | 46.64% |
| 2009 | 36.58 Million EUR | 3.61% |
| 2008 | 35.31 Million EUR | 17.45% |
| 2007 | 30.06 Million EUR | -18.37% |
| 2006 | 36.83 Million EUR | 57.64% |
| 2005 | 23.36 Million EUR | 25.13% |
| 2004 | 18.67 Million EUR | 27.05% |
| 2003 | 14.69 Million EUR | 30.68% |
| 2002 | 11.24 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 17.32 Million EUR | 32.68% |
| 2024 Q3 | 16.52 Million EUR | -4.61% |
| 2024 Q1 | 13.05 Million EUR | -37.37% |
| 2023 Q2 | 12.59 Million EUR | -5.31% |
| 2023 Q1 | 13.3 Million EUR | -17.51% |
| 2023 FY | 64.84 Million EUR | -18.42% |
| 2023 Q4 | 20.84 Million EUR | 15.2% |
| 2023 Q3 | 18.09 Million EUR | 43.66% |
| 2022 Q3 | 25.52 Million EUR | 67.71% |
| 2022 FY | 79.49 Million EUR | -9.37% |
| 2022 Q4 | 16.12 Million EUR | -36.83% |
| 2022 Q1 | 22.61 Million EUR | 35.38% |
| 2022 Q2 | 15.22 Million EUR | -32.7% |
| 2021 Q2 | 26.36 Million EUR | 15.83% |
| 2021 FY | 87.71 Million EUR | 27.14% |
| 2021 Q3 | 21.87 Million EUR | -17.01% |
| 2021 Q1 | 22.76 Million EUR | 29.2% |
| 2021 Q4 | 16.7 Million EUR | -23.64% |
| 2020 Q3 | 17.68 Million EUR | 3.88% |
| 2020 FY | 68.98 Million EUR | 32.41% |
| 2020 Q4 | 17.61 Million EUR | -0.37% |
| 2020 Q1 | 16.66 Million EUR | 18.55% |
| 2020 Q2 | 17.02 Million EUR | 2.12% |
| 2019 Q3 | 13.23 Million EUR | -3.28% |
| 2019 Q2 | 13.68 Million EUR | 23.03% |
| 2019 FY | 52.1 Million EUR | -2.57% |
| 2019 Q4 | 14.06 Million EUR | 6.23% |
| 2019 Q1 | 11.12 Million EUR | -21.7% |
| 2018 FY | 53.48 Million EUR | -20.77% |
| 2018 Q1 | 10.95 Million EUR | -36.89% |
| 2018 Q2 | 12.36 Million EUR | 12.89% |
| 2018 Q3 | 15.07 Million EUR | 21.97% |
| 2018 Q4 | 14.2 Million EUR | -5.78% |
| 2017 Q4 | 17.35 Million EUR | -3.87% |
| 2017 Q3 | 18.04 Million EUR | 15.2% |
| 2017 Q2 | 15.66 Million EUR | -4.63% |
| 2017 Q1 | 16.42 Million EUR | 4.32% |
| 2017 FY | 67.49 Million EUR | 9.51% |
| 2016 Q1 | 10.89 Million EUR | -29.26% |
| 2016 FY | 61.63 Million EUR | 12.0% |
| 2016 Q2 | 18.94 Million EUR | 73.84% |
| 2016 Q3 | 16.04 Million EUR | -15.31% |
| 2016 Q4 | 15.74 Million EUR | -1.84% |
| 2015 Q1 | 12.41 Million EUR | 35.34% |
| 2015 FY | 55.03 Million EUR | 22.47% |
| 2015 Q4 | 15.4 Million EUR | 8.85% |
| 2015 Q3 | 14.15 Million EUR | 8.39% |
| 2015 Q2 | 13.05 Million EUR | 5.13% |
| 2014 Q2 | 11.35 Million EUR | 1.09% |
| 2014 Q3 | 13.17 Million EUR | 16.06% |
| 2014 FY | 44.93 Million EUR | 7.6% |
| 2014 Q1 | 11.23 Million EUR | -12.04% |
| 2014 Q4 | 9.17 Million EUR | -30.36% |
| 2013 Q3 | 9.4 Million EUR | -1.23% |
| 2013 Q1 | 10.06 Million EUR | 234.91% |
| 2013 Q2 | 9.52 Million EUR | -5.35% |
| 2013 FY | 41.76 Million EUR | 5.54% |
| 2013 Q4 | 12.76 Million EUR | 35.71% |
| 2012 Q3 | 14.95 Million EUR | -8.53% |
| 2012 Q1 | 15 Million EUR | -15.91% |
| 2012 Q2 | 16.34 Million EUR | 8.94% |
| 2012 Q4 | -7.45 Million EUR | -149.89% |
| 2012 FY | 39.57 Million EUR | -37.13% |
| 2011 FY | 62.94 Million EUR | 17.33% |
| 2011 Q2 | 15.26 Million EUR | 12.39% |
| 2011 Q4 | 17.84 Million EUR | 12.29% |
| 2011 Q3 | 15.88 Million EUR | 4.11% |
| 2011 Q1 | 13.57 Million EUR | -65.64% |
| 2010 Q3 | 14.13 Million EUR | 6.9% |
| 2010 FY | 53.64 Million EUR | 46.64% |
| 2010 Q4 | 39.51 Million EUR | 179.64% |
| 2010 Q1 | 11.71 Million EUR | -53.93% |
| 2010 Q2 | 13.21 Million EUR | 12.87% |
| 2009 Q3 | -8.87 Million EUR | -182.38% |
| 2009 Q2 | 10.76 Million EUR | 15.8% |
| 2009 Q4 | 25.42 Million EUR | 386.55% |
| 2009 FY | 36.58 Million EUR | 3.61% |
| 2009 Q1 | 9.3 Million EUR | 0.0% |
| 2008 FY | 35.31 Million EUR | 17.45% |
| 2007 FY | 30.06 Million EUR | -18.37% |
| 2006 FY | 36.83 Million EUR | 57.64% |
| 2005 FY | 23.36 Million EUR | 25.13% |
| 2004 FY | 18.67 Million EUR | 27.05% |
| 2003 FY | 14.69 Million EUR | 30.68% |
| 2002 FY | 11.24 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Cegedim SA | 39.99 Million EUR | -62.145% |
| Guerbet SA | 589.46 Million EUR | 88.999% |
| Nexus AG | 65.97 Million EUR | 1.711% |
| Bastide Le Confort Médical SA | 46.83 Million EUR | -38.463% |
| Revenio Group Oyj | 45.27 Million EUR | -43.222% |
| Drägerwerk AG & Co. KGaA | 1.45 Billion EUR | 95.558% |
| Sartorius Aktiengesellschaft | 1.56 Billion EUR | 95.862% |
| LNA Santé SA | 82.71 Million EUR | 21.6% |
| Siemens Healthineers AG | 8.46 Billion EUR | 99.234% |
| Medios AG | 51.93 Million EUR | -24.848% |
| Equasens Société anonyme | 56.65 Million EUR | -14.454% |